None listed
Conditions
Brief summary
This study looks at the feasibility of using Technitium, injected via a bronchoscope, for the detection of the sentinel lymph node in suspected non-small cell lung cancer Who is it for? You can join this study if you are: - about to undergo flexible bronchoscopy for the diagnosis of suspected non-small cell lung cancer - 40-85 years of age - prepared to accept the 2% risk of developing a pneumothorax (collapsed lung) with this treatment. Trial details While having their scheduled bronchoscope, participants will receive injection of technetium dye into the region of the lung which has the lung cancer. The technetium will allow any sentinel lymph nodes to be identified by a non-invasive Nuclear Medicine imaging test called a SPECT/CT scans, 4 hours after the injection. The study will look at the effectiveness and safety of this procedure.
Interventions
Bronchoscopic injection, via transbronchial needle introduced into submucosal layer of bronchial wall, of technetium-99 (antimony colloid) into region of lung in which lung cancer resides.
Sponsors
Daniel Steinfort
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
patients undergoing flexible bronchoscopy for the diagnosis of suspected peripheral lung cancer
Exclusion criteria
Patient declines Mediastinal lymphadenopathy on computerized tomography (CT) chest medically unsuitable for bronchoscopy
Outcome results
None listed